Aurora Cannabis (ACB) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Aurora Cannabis Announces Fiscal 2023 First Quarter Results
November 10, 2022 4:10 PM ESTNASDAQ | TSX: ACB
Reiterates Reaching Adjusted EBITDA Profitability by December 31, 2022Reaffirms $150 to $170 Million in Annualized Cost Savings Achieved by December 31, 2022; $140 Million Realized to DateStrengthens Balance Sheet Through Accretive Debt Reduction of Approximately US$160 Million in 2022; Strong Cash Position of Approximately $393 millionRemains #1 Canadian LP in High Margin Global Medical Cannabis RevenuesEDMONTON, AB, Nov. 10, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:... More
